Table 3.

Extra-days length of hospitalization.

	nRV hospitalization (mean days ± SD)	Extra Length of stay (days)	nRV (Sample)	Sample size (tot)	Age range	Ref
Gleizes et al.	—	1.7—5.9a	—	70—5,470a	<18 y	21
Stefkovicova M et al.	7.32	3.4b	62	1,635	<5 y	23
Forster et al.	—	3.0	117	3,734	<5 y	24
Festini et al.	8.1 ± 5.4	1.7	28	608	<30 m	30
Gutiérrez-Gimeno et al.	7.5 ± 3.7	1.7	69	1,576	1—23 m	31
García-Basteiro et al.	9.7 ± 13.6	6b	892	355,339	<5 y	32
Panatto et al.	—	4.4 (SD: ±2.7)	22	20,690	<5 y	33
Nitsch-Osuch et al.	11.6 ± 0.4	7b	575	63,173	<18 y	35
Zlamy et al.	8.0	4.2b	106	652,557c	<18 y	20
	13.3	10b	4	305,393d
Konstantopoulos et al.	—	5 (range: 4—7)	8	22,963	<5 y	36
Anca et al.	—	5 (range: 1—10)	137	53,445	<5 y	37
Redondo-Gonzalez et al.	9	5b	49	9,602	<18 y	40

^arange from a review of studies in 6 European countries

^bExtrapolated

^cpre-vaccine era (2002—2005)

^dpost-vaccine era (2007—2008)